TIM-3 therapy for Alzheimer’s disease presents a groundbreaking approach that merges cancer treatment strategies with neurodegenerative challenges.This innovative therapy focuses on inhibiting the checkpoint molecule TIM-3, which plays a critical role in regulating the immune response of microglia in the brain.